| case report | Q2782326 |
| scholarly article | Q13442814 |
| P2093 | author name string | Kenneth Brown | |
| Linda W Jennings | |||
| Brandi Scott-Hoy | |||
| P2860 | cites work | Methanogens, methane and gastrointestinal motility | Q27693339 |
| Rifaximin therapy for patients with irritable bowel syndrome without constipation | Q28302405 | ||
| Effect of tea saponin on methanogenesis, microbial community structure and expression of mcrA gene, in cultures of rumen micro-organisms | Q33400081 | ||
| Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome | Q33441709 | ||
| Fiber and functional gastrointestinal disorders | Q33457556 | ||
| Systematic review of randomised controlled trials: probiotics for functional constipation | Q33521058 | ||
| A diet low in FODMAPs reduces symptoms of irritable bowel syndrome | Q34038352 | ||
| Methanogens: methane producers of the rumen and mitigation strategies | Q34160114 | ||
| Affinity of polyphenols for lipid bilayers | Q34174037 | ||
| Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis | Q34375829 | ||
| The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis | Q34431190 | ||
| Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome | Q34512846 | ||
| Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. | Q34579745 | ||
| Oral bisacodyl is effective and well-tolerated in patients with chronic constipation | Q34627970 | ||
| A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation | Q36417684 | ||
| Burden of digestive diseases in the United States part II: lower gastrointestinal diseases | Q37376496 | ||
| Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern | Q37396948 | ||
| Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects | Q37874146 | ||
| Quality of life in patients with irritable bowel syndrome | Q37888383 | ||
| Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis | Q37994513 | ||
| Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis | Q38104220 | ||
| American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation | Q38236812 | ||
| Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome | Q39224261 | ||
| Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies. | Q39311968 | ||
| Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS | Q42264073 | ||
| Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation | Q42632480 | ||
| Antispasmodic effect of Mentha piperita essential oil on tracheal smooth muscle of rats | Q43058195 | ||
| Methane production during lactulose breath test is associated with gastrointestinal disease presentation | Q44367935 | ||
| Pilot postoperative ileus study of escin in cancer patients after colorectal surgery | Q46217018 | ||
| Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity | Q46809151 | ||
| Escin: inhibiting inflammation and promoting gastrointestinal transit to attenuate formation of postoperative adhesions | Q46823581 | ||
| Botanical traceability of commercial tannins using the mineral profile and stable isotopes | Q46837613 | ||
| High Molecular Weight Plant Polyphenolics (Tannins) as Biological Antioxidants. | Q47290710 | ||
| Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. | Q51310014 | ||
| Antibiotic treatment of constipation-predominant irritable bowel syndrome. | Q51726426 | ||
| Effects of escins Ia, Ib, IIa, and IIb from horse chestnuts on gastrointestinal transit and ileus in mice | Q78246260 | ||
| P433 | issue | 3 | |
| P921 | main subject | constipation | Q178436 |
| irritable bowel syndrome | Q838966 | ||
| P304 | page(s) | 463-468 | |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | World journal of gastrointestinal pharmacology and therapeutics | Q27723537 |
| P1476 | title | Response of irritable bowel syndrome with constipation patients administered a combined quebracho/conker tree/M. balsamea Willd extract | |
| P478 | volume | 7 |
Search more.